Oct 1, 2024, 11:39
Marlise R. Luskin: Severe neutropenia is associated with blinatumomab
Marlise R. Luskin, leukemia specialist at Dana-Farber Cancer Institute, posted on X:
“Severe neutropenia is associated with blinatumomab! Blina is not considered myelosuppressive, but have observed severe neutropenia. We studied 95 pts receiving blina in CR at Dana-Farber Cancer Institute 41% gr≥3 neutropenia, 13% ANC <100, no serious infections, not necessarily recurrent!”
Source: Marlise R. Luskin/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 1, 2024, 11:39
Oct 1, 2024, 11:37
Oct 1, 2024, 11:32
Oct 1, 2024, 11:27
Oct 1, 2024, 11:26
Oct 1, 2024, 11:21
Oct 1, 2024, 11:20
Oct 1, 2024, 11:10
Oct 1, 2024, 11:05
Oct 1, 2024, 11:00